ISBRA 2006 World Congress on Alcohol Research

Session Details

GABAA and glycine receptors: potential model systems for the development of medications for the treatment of alcoholism

Monday, 11 September 2006 11:00 -12:30

Ballroom 3

Chair Daryl L Davies University of Southern CaliforniaUnited States
Co-Chair James R Trudell Stanford UniversityUnited States

Current understanding of the molecular pharmacology and physiology of the GABAa and glycine receptors
  • Peter R Schofield, Prince of Wales Medical Research Institute and University of New South Wales, Australia
  • High throughout screening of glycIne and GABAA receptors: why and how?
  • Joseph W Lynch, School of Biomedical Sciences, University of Queensland, Australia
  • Understanding the molecular details of extracellular ligand-binding sites of the GABAA receptor
  • Brett A Cromer, St Vincent’s Institute of Medical Research, Fitzroy, Vic 3065, Australia
  • Pharmacotherapy for Alcoholism: Novel Targets for Medication Development in ligand-gated ion channels
  • Daryl L Davies, University of Southern California, School of Pharmacy, United States
  • Developing Molecular Models for Alcohol Medications
  • James R Trudell, Department of Anesthesia, Stanford School of Medicine, Stanford, CA, 94305-5117, United States
  • Published on Thursday, 7 September 2006 by the Professional Conference Organiser